The Significance of Moving Averages in EyePoint Pharmaceuticals Inc Inc. (EYPT) Price Performance

TOST Stock

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 12.50%.However, over the last six months, we can see a weaker performance of 23.39%. Over the last 30 days, the price of EYPT has fallen by 63.93%. And in the last five days, it has surged by 3.15%.

EyePoint Pharmaceuticals Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $13.98 on 10/28/24, and the lowest price during the same period was recorded at $3.91 on 04/09/25.

52-week price history of EYPT Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. EyePoint Pharmaceuticals Inc’s current trading price is -34.36% away from its 52-week high, while its distance from the 52-week low is 134.78%. The stock’s price range over this timeframe has been between $3.91 and $13.98. The shares of the Healthcare sector company recorded a trading volume of approximately 0.85 million for the day, which was comparatively higher than the average daily volume of 0.82 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

EyePoint Pharmaceuticals Inc (EYPT) has experienced a quarterly rise of 44.79% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 631.69M and boasts a workforce of 165 employees.

How Moving Averages and Trading Volume Data Work Together

EYPT’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for EYPT stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.07.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.